A detailed history of M&T Bank Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, M&T Bank Corp holds 266,822 shares of LLY stock, worth $199 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
266,822
Previous 264,955 0.7%
Holding current value
$199 Million
Previous $240 Million 1.46%
% of portfolio
0.17%
Previous 0.82%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $1.44 Million - $1.79 Million
1,867 Added 0.7%
266,822 $236 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $25.7 Million - $32.2 Million
35,448 Added 15.45%
264,955 $240 Million
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $14 Million - $18.8 Million
23,669 Added 11.5%
229,507 $179 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $5.87 Million - $6.92 Million
-11,185 Reduced 5.15%
205,838 $120 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $2.97 Million - $4.1 Million
-6,835 Reduced 3.05%
217,023 $117 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $973,654 - $1.3 Million
-2,776 Reduced 1.22%
223,858 $105 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $2.72 Million - $3.2 Million
-8,770 Reduced 3.73%
226,634 $77.8 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $2.92 Million - $3.41 Million
9,095 Added 3.89%
242,692 $88.8 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $2.34 Million - $2.73 Million
-7,288 Reduced 3.0%
235,404 $86.1 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $858,309 - $978,133
2,895 Added 1.25%
233,597 $71.6 Million
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $9.99 Million - $11.7 Million
35,845 Added 18.4%
230,702 $64.2 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $1.45 Million - $1.81 Million
-6,198 Reduced 3.08%
194,857 $55.8 Million
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $1.03 Million - $1.27 Million
-4,567 Reduced 2.22%
201,055 $55.5 Million
Q3 2021

Oct 28, 2021

SELL
$221.6 - $272.71 $724,410 - $891,488
-3,269 Reduced 1.56%
205,622 $47.5 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $414,542 - $536,207
2,296 Added 1.11%
208,891 $47.9 Million
Q1 2021

May 06, 2021

SELL
$164.32 - $212.72 $1.84 Million - $2.39 Million
-11,217 Reduced 5.15%
206,595 $38.6 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $1.19 Million - $1.58 Million
-9,126 Reduced 4.02%
217,812 $36.8 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $283,081 - $327,435
-1,936 Reduced 0.85%
226,938 $33.6 Million
Q2 2020

Jul 29, 2020

SELL
$136.42 - $164.18 $848,805 - $1.02 Million
-6,222 Reduced 2.65%
228,874 $37.6 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $997,043 - $1.23 Million
-8,375 Reduced 3.44%
235,096 $32.6 Million
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $272,539 - $337,564
-2,549 Reduced 1.04%
243,471 $32 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $427,907 - $465,453
-4,007 Reduced 1.6%
246,020 $27.5 Million
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $656,319 - $766,091
-5,924 Reduced 2.31%
250,027 $27.7 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $173,532 - $204,260
-1,559 Reduced 0.61%
255,951 $33.2 Million
Q4 2018

Feb 01, 2019

SELL
$105.9 - $118.64 $928,848 - $1.04 Million
-8,771 Reduced 3.29%
257,510 $29.8 Million
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $19,919 - $24,895
-232 Reduced 0.09%
266,281 $28.6 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $1.54 Million - $1.77 Million
-20,317 Reduced 7.08%
266,513 $22.7 Million
Q1 2018

May 04, 2018

SELL
$74.21 - $87.6 $981,130 - $1.16 Million
-13,221 Reduced 4.41%
286,830 $22.2 Million
Q4 2017

Feb 06, 2018

SELL
$81.94 - $87.89 $471,810 - $506,070
-5,758 Reduced 1.88%
300,051 $25.3 Million
Q3 2017

Nov 13, 2017

SELL
$77.07 - $85.54 $358,298 - $397,675
-4,649 Reduced 1.5%
305,809 $26.2 Million
Q2 2017

Aug 11, 2017

BUY
N/A
310,458
310,458 $25.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.